15.03.2017 • NewsRoquettePharmaceuticalsbiopharmaceuticals

Roquette to Launch New Biopharmaceutical Brands

French family-owned group Roquette plans to introduce three new brands to address the growing demand for excipients and raw materials for the biopharmaceutical market.

The new product offerings are low endotoxin, multi-compendial grade materials for cell culture and biologic drug formulations.

"As a long-time leader in excipients and active ingredients for the pharmaceutical market, Roquette is proud to be part of this major therapeutic progress and is excited to introduce several new products in the US, Europe and Asia," said Paul Smaltz, VP of the Pharma global business unit.

With this investment the company wants to reaffirm its strategic initiatives to develop specialties for pharma, food, nutrition and health markets to accelerate global growth. According to Roquette the new protein-based drugs have the ability to put rheumatoid arthritis into remission and to transform many cancers into treatable conditions.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.